Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
August 12 Product: Ascendis Pharmas Yorvipath Indication: Hypoparathyroidism After a long regulatory road, Ascendis Pharma received FDA approval Monday for Yorvipath (TransCon PTH) for the treatment of hypoparathyroidism, a rare endocrine disease characterized by abnormally low levels of the parathyroid hormone
Sign effective contracts to maintain supply continuity If youre a pharma or biopharma company that frequently engages with key suppliers in the industry, its worth conducting strategic reviews of your contracts to ensure supply continuity and access to prioritised services
(2019) 51:e13162
Circulation, 138 (25), 29082918
Keep a 30-minute gap between glutathione and any dairy consumption
Building muscle through regular strength training helps maintain metabolism as weight drops, while prioritizing adequate protein intake supports lean mass and satiety, she says
